EU Commission: Suspend authorisation for non-compliant generic medicines tested by Synapse Labs
In agreement with EU Member States, and following an opinion by EMA, the Commission has today requested Member States to suspend the marketing authorisation for a list of generic medicines tested by the Indian company Synapse Labs, due to insufficient evidence about the reliability of testing data.